| Peyton P. Berookim, Md Inc | |
|
150 N Robertson Blvd Suite 204 Beverly Hills CA 90211 | |
| (310) 271-1122 | |
| Not Available |
| Full Name | Peyton P. Berookim, Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 150 N Robertson Blvd, Beverly Hills, California |
| Authorized Official Name and Position | Peyton Berookim (PRESIDENT) |
| Authorized Official Contact | 3102711122 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Peyton P. Berookim, Md Inc Po Box 67672 Los Angeles CA 90067-0065 Ph: (310) 273-7365 | Peyton P. Berookim, Md Inc 150 N Robertson Blvd Suite 204 Beverly Hills CA 90211 Ph: (310) 271-1122 |
| NPI Number | 1669618559 |
|---|---|
| Provider Enumeration Date | 12/23/2008 |
| Last Update Date | 11/01/2016 |
| Medicare PECOS PAC ID | 6901944529 |
|---|---|
| Medicare Enrollment ID | O20091118000547 |
News Archive
Universal Health Realty Income Trust announced today that for the quarter ended March 31, 2011, net income was $4.1 million, or $.33 per diluted share, as compared to $4.5 million, or $.37 per diluted share, during the same quarter in the prior year.
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart.
Mice genetically engineered to both overproduce the protein neuroglobin and to develop Alzheimer's disease (AD) had a much milder form of the disease when compared to mice engineered to have AD alone, researchers at the Buck Institute for Age Research have reported.
A new family of molecules that kill cancer cells and protect healthy cells could be used to treat a number of different cancers, including cervical, breast, ovarian and lung cancers. Research published in EBioMedicine shows that as well as targeting and killing cancer cells, the molecules generate a protective effect against toxic chemicals in healthy cells.
"Algeria will partner with the Joint United Nations Programme on HIV/AIDS (UNAIDS) to build the first HIV/AIDS research center in the Middle East and North Africa (MENA)," Nature Middle East reports.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669618559 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | A91789 (California) | Primary |
| Provider Name | Peyton P Berookim |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1770773830 PECOS PAC ID: 4183705528 Enrollment ID: I20080111000266 |
News Archive
Universal Health Realty Income Trust announced today that for the quarter ended March 31, 2011, net income was $4.1 million, or $.33 per diluted share, as compared to $4.5 million, or $.37 per diluted share, during the same quarter in the prior year.
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart.
Mice genetically engineered to both overproduce the protein neuroglobin and to develop Alzheimer's disease (AD) had a much milder form of the disease when compared to mice engineered to have AD alone, researchers at the Buck Institute for Age Research have reported.
A new family of molecules that kill cancer cells and protect healthy cells could be used to treat a number of different cancers, including cervical, breast, ovarian and lung cancers. Research published in EBioMedicine shows that as well as targeting and killing cancer cells, the molecules generate a protective effect against toxic chemicals in healthy cells.
"Algeria will partner with the Joint United Nations Programme on HIV/AIDS (UNAIDS) to build the first HIV/AIDS research center in the Middle East and North Africa (MENA)," Nature Middle East reports.
› Verified 4 days ago
| Provider Name | Lidija M Petrovic |
|---|---|
| Provider Type | Practitioner - Pathology |
| Provider Identifiers | NPI Number: 1457326266 PECOS PAC ID: 9234159344 Enrollment ID: I20081205000200 |
News Archive
Universal Health Realty Income Trust announced today that for the quarter ended March 31, 2011, net income was $4.1 million, or $.33 per diluted share, as compared to $4.5 million, or $.37 per diluted share, during the same quarter in the prior year.
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart.
Mice genetically engineered to both overproduce the protein neuroglobin and to develop Alzheimer's disease (AD) had a much milder form of the disease when compared to mice engineered to have AD alone, researchers at the Buck Institute for Age Research have reported.
A new family of molecules that kill cancer cells and protect healthy cells could be used to treat a number of different cancers, including cervical, breast, ovarian and lung cancers. Research published in EBioMedicine shows that as well as targeting and killing cancer cells, the molecules generate a protective effect against toxic chemicals in healthy cells.
"Algeria will partner with the Joint United Nations Programme on HIV/AIDS (UNAIDS) to build the first HIV/AIDS research center in the Middle East and North Africa (MENA)," Nature Middle East reports.
› Verified 4 days ago
News Archive
Universal Health Realty Income Trust announced today that for the quarter ended March 31, 2011, net income was $4.1 million, or $.33 per diluted share, as compared to $4.5 million, or $.37 per diluted share, during the same quarter in the prior year.
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart.
Mice genetically engineered to both overproduce the protein neuroglobin and to develop Alzheimer's disease (AD) had a much milder form of the disease when compared to mice engineered to have AD alone, researchers at the Buck Institute for Age Research have reported.
A new family of molecules that kill cancer cells and protect healthy cells could be used to treat a number of different cancers, including cervical, breast, ovarian and lung cancers. Research published in EBioMedicine shows that as well as targeting and killing cancer cells, the molecules generate a protective effect against toxic chemicals in healthy cells.
"Algeria will partner with the Joint United Nations Programme on HIV/AIDS (UNAIDS) to build the first HIV/AIDS research center in the Middle East and North Africa (MENA)," Nature Middle East reports.
› Verified 4 days ago
Treatmedngo Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8950 W Olympic Blvd Ste 103&104, Beverly Hills, CA 90211 Phone: 310-274-8080 | |
Refael Medical, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8200 Wilshire Blvd, Beverly Hills, CA 90211 Phone: 310-879-7167 Fax: 310-933-5688 | |
Michael D. Borookhim, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9301 Wilshire Blvd, Suite 602, Beverly Hills, CA 90210 Phone: 310-288-0881 | |
Ultrasound Specialists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9001 Wilshire Blvd, Suite 106, Beverly Hills, CA 90211 Phone: 310-273-8885 | |
Kaiser Permanente Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 S Arnaz Dr Apt 3, Beverly Hills, CA 90211 Phone: 213-215-5142 | |
Nancy P. Rahnama, M.d., A.p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 421 N Rodeo Dr, Penthouse Number 1, Beverly Hills, CA 90210 Phone: 310-299-7373 Fax: 310-432-6647 | |
Laurence Seigler, M.d. Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 435 N Bedford Dr, Suite 308, Beverly Hills, CA 90210 Phone: 310-274-6158 Fax: 310-274-5709 |